Cited by 7Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

New biologicals and biomaterials in the therapy of Alzheimer's disease

Prajapati, Vipul, Shinde, Shraddha, Shrivastav, Princy, Prajapati, Bhupendra Gopalbhai·2024·Alzheimer's Disease and Advanced Drug Delivery Strategies

DOI 10.1016/b978-0-443-13205-6.00016-9

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/b978-0-443-13205-6.00016-9

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alzheimer’s Disease
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,320
Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease
Kwon, H. J., Cha, M.-Y., Kim, D., Kim, D., Soh, M., Shin, K., Hyeon, T., & Mook‐Jung, I. (2016) · ACS Nano · doi:10.1021/acsnano.5b08045 · Cited by 667
Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease
Weekley, C. M., & Harris, H. H. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60272a · Cited by 645
Ceria Nanoparticles that can Protect against Ischemic Stroke
Kim, C. K., Kim, T., Choi, I., Soh, M., Kim, D., Kim, Y., Jang, H., Yang, H., Kim, J. Y., Park, H., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203780 · Cited by 592
Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer’s Disease Model via Canonical Wnt/β-Catenin Pathway
Tiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558
Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease
Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., & Kumar, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032616 · Cited by 454
Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease
Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 411
Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing
Chigurupati, S., Mughal, M. R., Okun, E., Das, S., Kumar, A., McCaffery, M. J., Seal, S., & Mattson, M. P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.061 · Cited by 377
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
Rizzo, L. Y., Theek, B., Storm, G., Kiessling, F. M., & Lammers, T. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.020 · Cited by 348
Negatively Charged Gold Nanoparticles Inhibit Alzheimer's Amyloid‐β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity
Liao, Y., Chang, Y., Yoshiike, Y., Chang, Y. C., & Chen, Y. (2012) · Small · doi:10.1002/smll.201201068 · Cited by 324
Memantine: A Review of Its Use in Alzheimer’s Disease
Robinson, D. M., & Keating, G. M. (2006) · Drugs · doi:10.2165/00003495-200666110-00015 · Cited by 277
Alzheimer disease: progress or profit?
Mount, C., & Downton, C. (2006) · Nature Medicine · doi:10.1038/nm0706-780 · Cited by 262
Ultrasensitive and Highly Selective Detection of Alzheimer’s Disease Biomarker Using Two-Photon Rayleigh Scattering Properties of Gold Nanoparticle
Neely, A., Candice, P., Varisli, B. Y., Singh, A. K., Arbneshi, T., Senapati, D., Kalluri, J. R., & Ray, P. C. (2009) · ACS Nano · doi:10.1021/nn900813b · Cited by 249
Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics
Akhtar, A., Andleeb, A., Waris, T. S., Bazzar, M., Moradi, A., Awan, N. R., & Yar, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.021 · Cited by 245
Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial
Rafii, M. S., Tuszynski, M. H., Thomas, R. G., Barba, D., Brewer, J. B., Rissman, R. A., Siffert, J., Aisen, P. S., & for the AAV2-NGF Study Team (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0233 · Cited by 219
Novel -penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
Cui, Z., Lockman, P. R., Atwood, C., Hsu, C. C., Gupte, A., ALLEN, D., & Mumper, R. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.009 · Cited by 203
Aducanumab for Alzheimer’s disease?
Walsh, S., Merrick, R. L., Milne, R., & Brayne, C. (2021) · BMJ · doi:10.1136/bmj.n1682 · Cited by 201
Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s disease
Yin, T., Yang, L., Liu, Y., Zhou, X., Sun, J., & Liu, J. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.06.035 · Cited by 198
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
Pardridge, W. M. (2020) · Pharmaceuticals · doi:10.3390/ph13110394 · Cited by 198
Tumor necrosis factor α Inhibition for Alzheimer’s Disease
Chang, R., Yee, K.-L., & Sumbria, R. K. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517709278 · Cited by 195
Alzheimer's and Parkinson's disease therapies in the clinic
Chopade, P., Chopade, N., Zhao, Z., Mitragotri, S., Liao, R., & Suja, V. C. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10367 · Cited by 187
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
Liu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G. L., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 177
Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease
Gupta, J., Fatima, M. T., Islam, Z., Khan, R. H., Uversky, V. N., & Salahuddin, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.156 · Cited by 163
An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factors
Kumar, V., Anand, R., Messina, J. C., Hartman, R. D., & Veach, J. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00046.x · Cited by 158
Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease
Yanagisawa, D., Shirai, N., Amatsubo, T., Taguchi, H., Hirao, K., Urushitani, M., Morikawa, S., Inubushi, T., Kato, M. G., Kato, F., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.142 · Cited by 157
Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
Carradori, D., Balducci, C., Re, F., Brambilla, D., Droumaguet, B. L., Flores, O., Gaudin, A., Mura, S., Forloni, G., Ordóñez‐Gutiérrez, L., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.006 · Cited by 143
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease
Roberts, M., Sevastou, I., Imaizumi, Y., Mistry, K., Talma, S., Dey, M., Gartlon, J., Ochiai, H., Zhou, Z., Akasofu, S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0884-2 · Cited by 135
Curcuminoids Promote Neurite Outgrowth in PC12 Cells through MAPK/ERK- and PKC-Dependent Pathways
Liao, K.-K., Wu, M., Chen, P., Huang, S., Chiu, S.-J., Ho, C., & Yen, J.-H. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf203290r · Cited by 120
Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
Chang, R., Knox, J., Chang, J. H., Derbedrossian, A., Vasilevko, V., Cribbs, D. H., Boado, R. J., Pardridge, W. M., & Sumbria, R. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00200 · Cited by 116
The Protective Role of Selenium on Scopolamine-Induced Memory Impairment, Oxidative Stress, and Apoptosis in Aged Rats: The Involvement of TRPM2 and TRPV1 Channels
Balaban, H., Nazıroğlu, M., Demirci, K., & Övey, İ. S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9835-0 · Cited by 104
Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection
Aso, E., Martinsson, I., Appelhans, D., Effenberg, C., Benseny‐Cases, N., Cladera, J., Gouras, G. K., Ferrer, I., & Klementieva, O. L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.010 · Cited by 101
Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
Bordoni, M., Scarian, E., Rey, F., Gagliardi, S., Carelli, S., Pansarasa, O., & Cereda, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093243 · Cited by 99
Mesenchymal Stem Cells Could Be Considered as a Candidate for Further Studies in Cell-Based Therapy of Alzheimer’s Disease via Targeting the Signaling Pathways
Farahzadi, R., Fathi, E., & Vietor, I. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00052 · Cited by 92
Commercial Scale Manufacturing of Allogeneic Cell Therapy
Pigeau, G. M., Csaszar, E., & Dulgar-Tulloch, A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00233 · Cited by 85
Biomaterials in treatment of Alzheimer's disease
Agrawal, M., Prathyusha, E., Ahmed, H., Dubey, S. K., Kesharwani, P., Singhvi, G., Naidu, V. G. M., & Alexander, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105008 · Cited by 82
Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease
Wong, L. R., & Ho, P. C. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12836 · Cited by 79
Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver
Schaffazick, S. R., Siqueira, I. R., Badejo, A. S., Jornada, D. S., Pohlmann, A. R., Netto, C. A., & Guterres, S. S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.11.010 · Cited by 64
An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Calhoun, A. J., King, C., Khoury, R., & Grossberg, G. T. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1519022 · Cited by 62
Biomaterials for the Treatment of Alzheimer’s Disease
Hadavi, D., & Poot, A. A. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00049 · Cited by 61
Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A
Yang, X., Yang, Y., Fu, Z., Li, Y., Feng, J. B., Luo, J., Zhang, Q., Wang, Q., & Tian, Q. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367723 · Cited by 57
Biomaterial-assisted scalable cell production for cell therapy
Chen, R., Li, L., Feng, L., Luo, Y., Xu, M., Leong, K. W., & Yao, R. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119627 · Cited by 56
Exosome-like Nanoparticles: A New Type of Nanocarrier
Fernandes, M., Lopes, I., Teixeira, J., Botelho, C., & Gomes, A. C. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190129142604 · Cited by 51
Novel Therapeutic Strategies for Alzheimer’s Disease: Implications from Cell-Based Therapy and Nanotherapy
Derakhshankhah, H., Sajadimajd, S., Jafari, S., Izadi, Z., Sarvari, S., Sharifi, M., Falahati, M., Moakedi, F., Muganda, W. C. A., Müller, M., et al. (2020) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2020.102149 · Cited by 48
Donepezil (Aricept®) for treatment of Alzheimer´s disease and other dementing conditions
Geldmacher, D. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.1.5 · Cited by 45
Current Therapeutic Targets for Alzheimer's Disease
Chaudhary, A., Maurya, P. K., Yadav, B. S., Singh, S., & Mani, A. (2018) · Journal of Biomedicine · doi:10.7150/jbm.26783 · Cited by 39
Self-Assembly of Proteins and Peptides and their Applications in Bionanotechnology
Subramani, K., Khraisat, A., & George, A. (2008) · Current Nanoscience · doi:10.2174/157341308784340831 · Cited by 29
Nanoparticles: A Step Forward for Iron Chelation in the Brain
Mandel, S. A., Amit, T., Machluf, M., & Youdim, M. B. H. (2007) · Future Neurology · doi:10.2217/14796708.2.3.265 · Cited by 10
Atorvastatin does not slow cognitive decline in patients with mild to moderate probable Alzheimer's disease who are taking donepezil
Fillit, H. M. (2010) · Evidence-Based Mental Health · doi:10.1136/ebmh1069 · Cited by 7

Sorted by citations

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56

See all 7

Authors: Prajapati, V., Shinde, S., Shrivastav, P., & Prajapati, B. G.
Affiliations: Savitribai Phule Pune University (IN)
Ganpat University (IN)
ORCID: Prajapati, Vipul
Shinde, Shraddha
Shrivastav, Princy
Prajapati, Bhupendra Gopalbhai
Venue: Alzheimer's Disease and Advanced Drug Delivery Strategies
Publisher: Elsevier
Published: 2024
Pages: 93-114
DOI: 10.1016/b978-0-443-13205-6.00016-9
OpenAlex: W4390967514
Cited by: 7
References: 51
Citations by year: 2026: 1 · 2025: 2 · 2024: 4
FWCI: 13.52
Type: book chapter
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Elsevier eBooks (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, biomaterials, biologicals, nanoparticles, metal nanoparticles, organic nanoparticles, cell therapy, dementia, drug delivery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

New biologicals and biomaterials in the therapy of Alzheimer's disease

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks